Europe — EMA

Orilukast (Montelukast Sodium)

Montelukast Sodium, the active ingredient in Orilukast, is a leukotriene receptor antagonist presented as a unknown/unknown for oral use. It treats asthma and allergic rhinitis in adults and children.

Montelukast Sodium

Request sourcing

Pack/s

What is Montelukast Sodium?

GNH USA supplies Orilukast as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Montelukast Sodium used for?

Orilukast is a leukotriene‑modifying agent that addresses …

- Asthma: … ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - Allergic rhinitis … … … … … … - Exercise‑‑ … … … … … ... ... … - Chronic … … … … … … … … … … … … ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →